Who Owns the Pulse? What Health Lawyers Need to Know About Licensing Patient Data in the Age of AI

When patient data becomes the raw material for AI, who actually governs it and for whose benefit? Mir Masud-Elias, Counsel, Arnold & Porter, and Mala Sahai, Senior Director, Intellectual Property and Legal Affairs, Gladstone Institutes, discuss the shift from data sharing as an administrative function to data licensing as a regulated risk transfer. They cover the multiple regulatory regimes (from state to federal to international); data types and classification risks; ownership, control, and governance; the three HIPAA pathways; core contract architecture; AI clauses, bias, validation, audit, and lifecycle risk; federated learning; patent versus trade secret strategy; and direct versus indirect monetization. Mir authored a Health Law Weekly article on this topic.Watch this episode: https://www.youtube.com/watch?v=IkKVzg0VPJMRead Mir’s Health Law Weekly article: https://www.americanhealthlaw.org/content-library/health-law-weekly/2026/april/3/who-owns-the-pulse-what-health-system-lawyers-need Essential Legal Updates, Now in AudioAHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Comprehensive members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.Stay At the Forefront of Health Legal EducationLearn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.